Skip to main content
Log in

Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Recent data indicates that chronic inflammation of the intestine such as Crohn's or ulcerative colitis puts those individuals at heightened risk for colorectal adenocarcinoma. In this study, we examine the effect of the inflammatory mediator PGE2 and associated signalling on detachment-induced cell death (anoikis) in intestinal epithelial cells. Treatment of detached IEC-18 with 0.01–0.05 μM PGE2 increased cell viability as well as induced aggregation. As EP4 prostaglandin receptors on IEC are coupled to adenylate cyclase, we next treated cells with agents that promote cAMP signalling (Forskolin, dbcAMP, and etazolate), all of which promoted IEC aggregation as well as survival. We next treated detached IECs with specific inhibitors of adenylate cyclase or PKA, which accelerated anoikis. To explore the mechanism of cell-cell adhesion, we next treated detached IECs with an anti-E-cadherin blocking antibody which dispersed aggregates induced by dbcAMP, and an adenovirus expressing a dominant negative E-cadherin (EcadΔEC) prevented aggregate formation. Interestingly EcadΔEC prevented aggregation of IEC induced by dbcAMP but did not significantly reduce viability. This suggests that cAMP signalling is important in both aggregate formation and promoting viability but these are distinct events. Taken together, these data support a mechanism whereby elevated PGE2 levels characteristic of colitis prevent anoikis by activating an AC-, cAMP-, and PKA-dependent signalling pathway. The delay of apoptosis by PGE2 may be one mechanism by which inflammation may contribute to carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kolios G, Petoumenos C, Nakos A. Mediators of inflammation: Production and implication in inflammatory bowel disease. Hepato-Gastroenterology 1998; 45: 1601–1609.

    CAS  PubMed  Google Scholar 

  2. Valentijn AJ, Metcalfe AD, Kott J, Streuli CH, Gilmore AP. Spatial and temporal changes in Bax subcellular localization during anoikis. J Cell Biol 2003; 162: 599–612.

    Article  CAS  PubMed  Google Scholar 

  3. Grossmann J, Artinger M, Grasso AW,et al. Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology 2001; 120: 79–88.

    Article  CAS  PubMed  Google Scholar 

  4. Grossmann J, Mohr S, Lapetina EG, Fiocchi C, Levine AD. Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol: Gastrointest Liver Physiol 1998; 274: G1117–G1124.

    CAS  Google Scholar 

  5. Nishihara H, Kizaka-Kondoh S, Insel PA, Eckmann L. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc Natl Acad Sci USA 2003; 100: 8921–8926.

    Article  CAS  PubMed  Google Scholar 

  6. Zou T, Rao JN, Guo X,et al. NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am J Physiol Cell Physiol 2004; 286: C1009–C1018.

    CAS  PubMed  Google Scholar 

  7. Harada H, Grant S. Apoptosis regulators. Rev Clin Exp Hematol 2003; 7: 117–138.

    CAS  PubMed  Google Scholar 

  8. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 1034–1039.

    Article  CAS  PubMed  Google Scholar 

  9. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619–626.

    Article  CAS  PubMed  Google Scholar 

  10. Swan EA, Jasser SA, Holsinger FC, Doan D, Bucana C, Myers JN. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol 2003; 39: 648–655.

    Article  CAS  PubMed  Google Scholar 

  11. Fernandez Y, Gu B, Martinez A, Torregrosa A, Sierra A. Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state. Int J Cancer 2002; 101: 317–326.

    CAS  PubMed  Google Scholar 

  12. Bates RC, Buret A, van Helden DF, Horton MA, Burns GF. Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994; 125: 403–415.

    Article  CAS  PubMed  Google Scholar 

  13. Waterhouse CCM, Joseph RR, Stadnyk AW. Endogenous IL-1 and type II IL-1 receptor expression modulate anoikis in intestinal epithelial cells. Exper Cell Res 2001; 269: 109–116.

    CAS  Google Scholar 

  14. Smida RS, Honore S, Rognoni JB, Martin PM, Penel C. Up-regulation of alpha 2 beta 1 integrin cell-surface expression protects A431 cells from epidermal growth factor-induced apoptosis. Int J Cancer 2000; 87: 360–367.

    Google Scholar 

  15. Rainaldi G, Calcabrini A, Arancia G, Santini MT. Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids. Anticancer Res 1999; 19: 1769–1778.

    CAS  PubMed  Google Scholar 

  16. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953–16961.

    Article  CAS  PubMed  Google Scholar 

  17. Shen X, Kramer RH. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol 2004; 165: 1315–1329.

    CAS  PubMed  Google Scholar 

  18. Jabbour HN, Kelly RW, Boddy SC. Autocrine/paracrine regulation of apoptosis in epithelial cells by prostaglandin E2. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 357–363.

    Article  CAS  PubMed  Google Scholar 

  19. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18(Suppl 2): 1–5.

    Google Scholar 

  20. Hanakawa Y, Amagai M, Shirakata Y, Sayama K, Hashimoto K. Different effects of dominant negative mutants of desmocollin and desmoglein on the cell-cell adhesion of keratinocytes. J Cell Sci 2000; 113 (Pt 10): 1803–1811.

    Google Scholar 

  21. Korchak HM, Rich AM, Wilkenfeld C, Rutherford LE, Weissmann G. A carbocyanine dye, DiOC6(3), acts as a mitochondrial probe in human neutrophils. Biochem Biophys Res Commun 1982; 108: 1495–1501.

    Article  CAS  PubMed  Google Scholar 

  22. Turunen JP, Mattila P, Renkonen R. cAMP mediates IL-1-induced lymphocyte penetration through endothelial monolayers. J Immunol 1990; 145: 4192–4197.

    CAS  PubMed  Google Scholar 

  23. Zhang YH, Lin JX, Yip YK, Vilcek J. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci USA 1988; 85: 6802–6805.

    CAS  PubMed  Google Scholar 

  24. Bonazzi A, Bolla M, Buccellati C, et al. Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells. Am J Respir Crit Care Med 2000; 162: 2272–2277.

    CAS  PubMed  Google Scholar 

  25. Rauk PN, Chiao JP. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am J Reprod Immunol 2000; 43: 152–159.

    CAS  PubMed  Google Scholar 

  26. Endo T, Ogushi F, Sone S, et al. Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. Am J Respir Cell Mol Biol 1995; 12: 358–365.

    CAS  PubMed  Google Scholar 

  27. Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: Mediation via a novel inducible cyclooxygenase. Placenta 1993; 14: 615–625.

    CAS  PubMed  Google Scholar 

  28. Ding M, Kinoshita Y, Kishi K, et al. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 1997; 53: 199–216.

    CAS  PubMed  Google Scholar 

  29. Nitta M, Hirata I, Toshina K, et al. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 2002; 56: 66–75.

    Article  CAS  PubMed  Google Scholar 

  30. Takafuji V, Cosme R, Lublin D, Roche JK. Prostanoid receptors in intestinal epithelium: Selective expression, function, and change with inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2000; 63: 223–235.

    Article  CAS  PubMed  Google Scholar 

  31. Alpaugh ML, Barsky SH. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Hum Gene Ther 2002; 13: 1245–1258.

    Article  CAS  PubMed  Google Scholar 

  32. Desoize B, Gimonet D, Jardiller JC. Cell culture as spheroids: An approach to multicellular resistance. Anticancer Res 1998; 18: 4147–4158.

    CAS  PubMed  Google Scholar 

  33. Bates RC, Goldsmith JD, Bachelder RE, et al. Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Current Biology 2003; 13: 1721–1727.

    Article  CAS  PubMed  Google Scholar 

  34. Xing H, Gao QL, Yang XK, et al. Resistance of multicellular spheroids to taxol in human ovarian cancer and its mechanism. Ai Zheng 2003; 22: 826–830.

    PubMed  Google Scholar 

  35. Ferrandez A, Prescott S, Burt RW. COX-2 and colorectal cancer. Curr Pharm Des 2003; 9: 2229–2251.

    Article  CAS  PubMed  Google Scholar 

  36. Oshimoto H, Okamura S, Yoshida M, Mori M. Increased activity and expression of phospholipase D2 in human colorectal cancer. Oncol Res 2003; 14: 31–37.

    CAS  PubMed  Google Scholar 

  37. Yu HG, Huang JA, Yang YN, et al. Inhibition of cytosolic phospholipase A2 mRNA expression: A novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells. Regul Pept 2003; 114: 101–107.

    Article  CAS  PubMed  Google Scholar 

  38. Wendum D, Svrcek M, Rigau V, et al. COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 2003; 16: 130–136.

    Article  PubMed  Google Scholar 

  39. Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 2002; 47: 894–904.

    Article  CAS  PubMed  Google Scholar 

  40. Belley A, Chadee K. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology 1999; 117: 1352–1362.

    Article  CAS  PubMed  Google Scholar 

  41. Yan SR, Joseph RR, Rosen K, et al. Activation of NF-kB following detachment delays apoptosis in intestinal epithelial cells. Oncogene 2005 (in press).

  42. Hintermann E, Yang N, O’Sullivan D, Higgins JM, Quaranta V. Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. J Biol Chem 2005; 280: 8004–8015.

    CAS  PubMed  Google Scholar 

  43. Okamoto R, Irie K, Yamada A, Katata T, Fukuhara A, Takai Y. Recruitment of E-cadherin associated with alpha- and beta-catenins and p120 to the nectin-based cell-cell adhesion sites by the action of 12-O-tetradecanoylphorbol-13-acetate in MDCK cells. Genes Cells 2005; 10: 435–445.

    Article  CAS  PubMed  Google Scholar 

  44. Fouquet S, Lugo-Martinez VH, Faussat AM, et al. Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J Biol Chem 2004; 279: 43061–43069.

    Article  CAS  PubMed  Google Scholar 

  45. Day ML, Zhao X, Vallorosi CJ, et al. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J Biol Chem 1999; 274: 9656–9664.

    CAS  PubMed  Google Scholar 

  46. Nightingale J, Chaudhary KS, Abel PD, et al. Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia 2003; 5: 347–361.

    CAS  PubMed  Google Scholar 

  47. Bergin E, Levine JS, Koh JS, Lieberthal W. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol Renal Physiol 2000; 278: F758–F768.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. W. Stadnyk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joseph, R.R., Yazer, E., Hanakawa, Y. et al. Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18. Apoptosis 10, 1221–1233 (2005). https://doi.org/10.1007/s10495-005-2049-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-005-2049-y

Key words

Navigation